Módszerek összehasonlítása

	MelasQoL (Melasma Életminőség Skála)	Gyermekek Bőrtünetek Életminőség Indexe (cDLQI)
Tudományterület	Bőrgyógyászat	Bőrgyógyászat
Módszercsalád	Process / pipeline	Process / pipeline
Keletkezés éve	2006	1995
Megalkotó	Cestari TF, Hexsel D	Lewis-Jones MS, Finlay AY
Típus	Self-report	Self-report (parent or child proxy)
Alapmű	Cestari TF, Hexsel D, Brandt FS, et al. Validation of a melasma quality of life questionnaire for Brazilian Portuguese language: the MelasQoL. Br J Dermatol. 2006;156(Suppl 3):13-20.	Lewis-Jones MS, Finlay AY. The Children's Dermatology Life Quality Index (cDLQI): initial validation and practical use. Br J Dermatol. 1995;132(6):942-949.
Alternatív nevek	Melasma-QoL	cDLQI, Pediatric DLQI
Kapcsolódó	3	3
Összefoglaló	MelasQoL is a disease-specific, patient-administered quality-of-life measure designed to assess the psychosocial burden of melasma, a common chronic disorder of symmetric facial hyperpigmentation. Developed by Cestari and colleagues in 2006, it captures the unique emotional and social impacts of a predominantly cosmetic condition that disproportionately affects women of color. MelasQoL is essential in clinical trials and observational studies of melasma treatments to ensure that efficacy encompasses meaningful quality-of-life outcomes.	The Children's Dermatology Life Quality Index (cDLQI) is a pediatric-adapted version of the adult DLQI, measuring the impact of skin disease on quality of life in children and adolescents aged 4–16 years. Developed by Lewis-Jones and Finlay in 1995, it uses child-friendly language and addresses domains relevant to childhood (school, leisure, friendships, clothing) rather than work and adult relationships. cDLQI is the standard quality-of-life measure in pediatric dermatology trials and clinical practice.